GGrantIndex
← Search

Durvalumab in Combination with Olaparib in Non-Small Cell Lung Cancer

$163,158ZIAFY2024CANIH

Division Of Basic Sciences - Nci

Investigators

Linked publications & trials

View original record on NIH RePORTER →
Durvalumab in Combination with Olaparib in Non-Small Cell Lung Cancer · GrantIndex